Logo Design

Web Design

Logo Design

Web Design

Visual Analytics

Alzheimer’s Biomarker Consortium - Down Syndrome

Alzheimer’s Biomarker Consortium - Down Syndrome

PROJECT DETAILS

ABC-DS is a clinical trial run by the University of Pittsburgh. The client came to Wondros with a traffic and audience retention issue. We were asked to create a 5 page web product that clearly articulates the goals and needs of the project that could be clearly understood by both potential clinical trial participants (people with DS) as well as caregivers.


It was important to our client to create a brand that would be playful and fun with serious undertones. To draw in our user base while clearly instructing the user as to what the goals of the clinical trial are.

Wireframing

I collaborated closely with the UX designer and research team to translate insights into actionable wireframes. My role included organizing content, mapping user flows, and creating low-fidelity prototypes that clarified complex processes for participants and caregivers.


This groundwork ensured the final designs were intuitive, accessible, and aligned with the project’s recruitment goals.

Brand guidelines

I developed a comprehensive design system for the project, establishing typography guidelines and a cohesive illustration style to unify the brand across all digital touchpoints.


This system ensured visual consistency, accessibility, and scalability, making it easier for the team to produce new assets while maintaining a recognizable identity.


Along with the branding guidelines I created the logo and logo lockup to accurately reflect the brand.


Final Web Product

I led the UI design for the Alzheimer’s Biomarker Consortium – Down Syndrome project, creating a digital presence that was both informative and approachable for caregivers and participants. In addition to designing the interface, I developed the branding system, logo, photography style, and custom illustrations to give the project a cohesive and empathetic visual identity.


My goal was to make complex clinical information feel clear and welcoming, ensuring users could easily understand the trial and how to get involved.